Drug Type Small molecule drug |
Synonyms 4-Sulfanilamido-5,6-dimethoxypyrimidine, Sulfadoxine (JAN/USP/INN), Sulforthomidine + [5] |
Target |
Mechanism bacterial DHPS inhibitors(Bacterial dihydropteroate synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (31 Dec 1989), |
Regulation- |
Molecular FormulaC12H14N4O4S |
InChIKeyPJSFRIWCGOHTNF-UHFFFAOYSA-N |
CAS Registry2447-57-6 |
Start Date01 Jul 2005 |
Sponsor / Collaborator |
Start Date01 Mar 2004 |
Sponsor / Collaborator |
Start Date01 Sep 2003 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00580 | Sulfadoxine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | CN | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |